Agent derived from tortoise spleen stimulating mammalian hemopoiesis
AssigneeBMR Solutions Ltd.
InventorAzim Turdiev
Life of this patent
Estimating the term…
Abstract
The present invention relates to a proteinaceous extract derived from tortoise spleen and to a tetrapeptide FTGN, which have stimulatory activity on hematopoietic cells. In particular, this tetrapeptide enhances hemopoietic reconstruction, and bone marrow re-population, reduced as a consequence of a high dose of radiation or chemotherapy exposure. The invention further provides pharmaceutical compositions comprising as an effective ingredient the proteinaceous extract or the FTGN tetrapeptide and ex vivo and in vivo methods of treatment employing them.
Claims2
A method of stimulating proliferation of hematopoietic cells in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of an isolated peptide comprising the amino acid sequence FTGN (SEQ ID NO:
- 1), wherein the combined molecular weight of all amino acids contained within said peptide is lower than 2 kDa.
Dependencies are inferred from the claim text.